[
    [
        {
            "time": "",
            "original_text": "[强于大市评级]医药行业2017年年报及2018年一季报总结：18Q1业绩加速明显 支持医药板块持续牛市",
            "features": {
                "keywords": [
                    "医药",
                    "2017年报",
                    "2018一季报",
                    "18Q1业绩",
                    "加速",
                    "牛市"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[强于大市评级]医药行业2017年年报及2018年一季报总结：18Q1业绩加速明显 支持医药板块持续牛市",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "[看好评级]医药生物行业周报：降价控费再下一城 政策落地提速",
            "features": {
                "keywords": [
                    "医药生物",
                    "降价控费",
                    "政策",
                    "落地提速"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "[看好评级]医药生物行业周报：降价控费再下一城 政策落地提速",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[推荐评级]医药生物行业事件点评报告：2017年&2018年Q1医药财报分析靓丽业绩开端 中长期更值得期待",
            "features": {
                "keywords": [
                    "医药生物",
                    "2017年",
                    "2018年Q1",
                    "财报",
                    "靓丽业绩",
                    "中长期"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[推荐评级]医药生物行业事件点评报告：2017年&2018年Q1医药财报分析靓丽业绩开端 中长期更值得期待",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "[强于大市评级]医药生物行业研究周报：医药浪潮有望填平低估洼地 消费升级盛夏高潮迭起",
            "features": {
                "keywords": [
                    "医药生物",
                    "医药浪潮",
                    "低估洼地",
                    "消费升级",
                    "高潮迭起"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[强于大市评级]医药生物行业研究周报：医药浪潮有望填平低估洼地 消费升级盛夏高潮迭起",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "[审慎增持评级]片仔癀(600436)季报点评：核心品种持续放量 业绩再超预期",
            "features": {
                "keywords": [
                    "片仔癀",
                    "核心品种",
                    "放量",
                    "业绩",
                    "超预期"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[审慎增持评级]片仔癀(600436)季报点评：核心品种持续放量 业绩再超预期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "东吴：医药上市企业业绩稳步提升 行业向上趋势显著",
            "features": {
                "keywords": [
                    "医药",
                    "上市企业",
                    "业绩",
                    "稳步提升",
                    "向上趋势"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "东吴：医药上市企业业绩稳步提升 行业向上趋势显著",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]